Abstract:High-risk human papillomavirus (HPV)16/18 infection in the development of lung cancer has previously been identified, and fragile histidine triad (FHIT) loss and p53 mutation are frequently observed in the disease. However, the association between these factors has not been well studied. The present study aimed to further investigate the significance of HPV infection, FHIT loss and p53 mutations in the development of lung cancer and their possible associations. DNA was extracted from paraffin-embedded specimens from 88 cases of squamous cell carcinoma (SCC), 56 of adenocarcinoma (AC), 36 of small cell lung carcinoma (SCLC) and 110 non-cancer control cases of lung neoplasms. The prevalence of HPV infection was determined by polymerase chain reaction analysis, and FHIT loss and p53 mutations were detected by immunohistochemistry. The (2), Fisher's exact and Pearson correlation tests were applied for statistical analysis. The results of the present study demonstrated that HPVL1 (the major capsid protein of HPV), HPV16 and HPV18 infection were more prevalent in the lung cancer samples compared with the non-cancer controls (all P<0.001). FHIT loss occurred more frequently in the lung cancer samples (44.44%) compared with the non-cancer controls (7.25%) (P<0.001). FHIT loss in the HPVL1-positive group was significantly increased compared with the HPVL1-negative group in the lung cancer cases and the non-cancer controls (P<0.05). In the lung cancer cases, the p53 mutation rates in the HPVL1- and HPV16/18-positive groups were significantly increased compared with the HPVL1- and HPV16/18-negative groups (P<0.05). In the 180 lung cancer cases, the coexistence rate of FHIT loss and a history of smoking was 38.33% (69/180; Pearson contingency coefficient of r=0.318; P<0.001). FHIT loss and p53 mutation exhibited a synergistic effect on HPV-associated lung cancer (Pearson contingency coefficient r=0.357, P<0.001). The present study demonstrated that FHIT loss may be important in the occurrence of lung cancer, particularly in lung SCCs. FHIT loss may therefore be used as an early indicator for lung cancer, particularly for patients with a history of smoking. HPV infection in lung tumorigenesis may, at least in part, be mediated through FHIT loss. FHIT loss and p53 mutation may coordinate together in the development of HPV-associated lung cancer, and accelerate the occurrence and development of lung cancer.

[Association Between Human Papillomavirus Infection and Lung Cancer].

Prevalence of human papillomavirus infection in women with uterine cervical cancer in Wenzhou

Correlation between human papillomavirus multi-infection,age and cervical disease

Low Prevalence of Human Papillomavirus (hpv) in Chinese Patients with Breast Cancer

Significance of human papillomavirus 16/18 infection in association with p53 mutation in lung carcinomas.

Prevalence of High-Risk Human Papillomavirus and Cervical Lesion Risk Factors: A Population-Based Study in Zhejiang, China 2010-2019

No role for human papillomavirus in esophageal squamous cell carcinoma in China.

Human Papillomavirus Infection in 674 Chinese Patients with Laryngeal Squamous Cell Carcinoma.

The Study of Human Papillomavirus Genotyping in Cervical Cancer

Correlation between human papillomavirus infection and the pathogenesis and prognosis of laryngeal squamous cell carcinoma

Effect of FHIT loss and p53 mutation on HPV-infected lung carcinoma development

Human papillomavirus prevalence and type-distribution among women in Zhejiang Province, Southeast China: a cross-sectional study

No genetic causal association between human papillomavirus and lung cancer risk: a bidirectional two-sample Mendelian randomization analysis

Correlation Between Squamous Cell Carcinoma of the Lung and Human Papillomavirus Infection and the Relationship to Expression of P53 and P16

[Association Between HPV DNA and Disease Specific Survival in Patients with Penile Cancer].

HPV Seropositivity Joints with Susceptibility Loci Identified in GWASs at Apoptosis Associated Genes to Increase the Risk of Esophageal Squamous Cell Carcinoma (ESCC)

HPV and Lung Cancer: A Systematic Review

Epidemiology of Humanpapilloma virus infection among women in Fujian, China

Metaanalysis of relationship between tumorigenesis of esophageal carcinoma and human papillomavirus infection

Statistical Analysis of Human Papillomavirus in A Subset of Upper Aerodigestive Tract Tumors

High-risk human papillomavirus infection in patients with lung cancer and its related mechanism